Check if Lumify changes eye redness and pressure in glaucoma
Part of Eyes & vision clinical trials.
This study tests whether Lumify™ eye drops affect eye redness, eye pressure, and eyelid position in people with primary open-angle glaucoma. It may help doctors understand how “whitening” eye drops could interact with glaucoma treatment and symptoms.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are older than 18 years
- You have primary open-angle glaucoma
- You can read and sign informed consent (agree to participate)
- You have been using brimonidine eye drops at least 6 weeks in the past and are currently using it
- You have no known allergy or sensitivity to brimonidine
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if adding brimonidine eye drops can reduce eye redness caused by the glaucoma drops you are currently taking. It may help if you have been using netarsudil/latanoprost drops and have noticed redness.
This Phase 3 study compares two versions of the same glaucoma eye-drop medicine (bimatoprost 0.01%) to see how similarly they work and their effect on eye pressure. It may help people with chronic open-angle glaucoma or ocular hypertension who need treatment in both eyes.
This study measures inflammation markers on the eye surface in people with primary open-angle glaucoma or ocular hypertension who use certain glaucoma drops. The results may help doctors understand how these drops affect the eye and inflammation.
This study uses a special camera (Brillouin microscopy) to measure how stiff your cornea is. It compares people with different types of glaucoma to those without glaucoma, helping researchers understand the link between corneal stiffness and eye pressure.
This study tests a new eye drop against an existing one to see which better lowers eye pressure in people with open-angle glaucoma or ocular hypertension. You may be able to join if you have high eye pressure in both eyes that needs treatment and you are at least 18 years old.
This study compares two eyedrop treatments—Upneeq and Lumify—to see which works better for acquired droopy eyelid (ptosis). It may help you if you have a droopy eyelid that makes it harder to see or affects your appearance.
Hear when a new Glaucoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.